Abstract
As microbes use many mechanisms for avoiding immunological pressure, new strategies must be developed to bypass the immunological code of silence of conserved, functionally-important amino acid sequences, such as those involved in high activity binding peptides (HABPs) attaching to their host cells. Hundreds of experiments in large numbers of Aotus monkeys revealed that this immunological code of silence could be broken by shifting the polarity of some critical host cell binding residues in these HABPs by substituting F for R and vice versa, YW, LH, IN, PD, MK or E, CT, VN or S; there are special rules for A, G and S. 1H-nuclear magnetic resonance of these modified, immunogenic, protection-inducing HABPs and molecular modelling revealed that such modifications induced appropriate fitting into specific HLA-DRβ1* Pockets, suggesting the presence of new pockets and a haplotype- and allele-specific conscious TCR. A highly immunogenic and protection-inducing anti-malarial vaccine can thus be produced.
Keywords: Malaria, P. falciparum, 1H-NMR, HLA-DRβ1* molecules, immunogenic peptides
Medicinal Chemistry
Title: Shifting the Polarity of some Critical Residues in Malarial Peptides Binding to Host Cells is a Key Factor in Breaking Conserved Antigens Code of Silence
Volume: 4 Issue: 3
Author(s): G. Cifuentes, A. Bermudez, R. Rodriguez, M. A. Patarroyo and M. E. Patarroyo
Affiliation:
Keywords: Malaria, P. falciparum, 1H-NMR, HLA-DRβ1* molecules, immunogenic peptides
Abstract: As microbes use many mechanisms for avoiding immunological pressure, new strategies must be developed to bypass the immunological code of silence of conserved, functionally-important amino acid sequences, such as those involved in high activity binding peptides (HABPs) attaching to their host cells. Hundreds of experiments in large numbers of Aotus monkeys revealed that this immunological code of silence could be broken by shifting the polarity of some critical host cell binding residues in these HABPs by substituting F for R and vice versa, YW, LH, IN, PD, MK or E, CT, VN or S; there are special rules for A, G and S. 1H-nuclear magnetic resonance of these modified, immunogenic, protection-inducing HABPs and molecular modelling revealed that such modifications induced appropriate fitting into specific HLA-DRβ1* Pockets, suggesting the presence of new pockets and a haplotype- and allele-specific conscious TCR. A highly immunogenic and protection-inducing anti-malarial vaccine can thus be produced.
Export Options
About this article
Cite this article as:
Cifuentes G., Bermudez A., Rodriguez R., Patarroyo A. M. and Patarroyo E. M., Shifting the Polarity of some Critical Residues in Malarial Peptides Binding to Host Cells is a Key Factor in Breaking Conserved Antigens Code of Silence, Medicinal Chemistry 2008; 4 (3) . https://dx.doi.org/10.2174/157340608784325160
DOI https://dx.doi.org/10.2174/157340608784325160 |
Print ISSN 1573-4064 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6638 |
Call for Papers in Thematic Issues
Biomolecules in Medicinal and Pharmaceutical Chemistry for Drug Development
Medicinal chemists play a vital role in the drug development process by identifying and synthesizing molecules that define structure-activity correlations and ensure efficacy and safety in preclinical animal testing. The fields of medicinal chemistry and pharmaceutical chemistry constitute an analogy that has the potential to encourage a beneficial relationship between ...read more

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Occurrence of DAT1 (VNTR) Polymorphism in Individuals with HIV Infection
Current Pharmacogenomics and Personalized Medicine Radziszewski Reaction: An Elegant, Easy, Simple and Efficient Method to Synthesise Imidazoles
Current Organic Synthesis Synthesis and In Vitro Evaluation of Some Hydrazone Derivatives as Potential Antibacterial Agents
Letters in Drug Design & Discovery Synthesis and Functionalization of Coumarin-Pyrazole Scaffold: Recent Development, Challenges, and Opportunities
Current Organic Synthesis Synthesis of Cinnamide Dimers as Potential Antibacterial and Antifungal Agents
Letters in Drug Design & Discovery Trypanosomatid Parasites Causing Neglected Diseases
Current Medicinal Chemistry Nanocarriers for Systemic and Mucosal Vaccine Delivery
Recent Patents on Drug Delivery & Formulation Safety of Using Copper Oxide in Medical Devices and Consumer Products
Current Chemical Biology Formulation of Nanosuspensions as a New Approach for the Delivery of Poorly Soluble Drugs
Current Nanoscience Synthesis and SAR Study of Simple Aryl Oximes and Nitrofuranyl Derivatives with Potent Activity Against Mycobacterium tuberculosis
Letters in Drug Design & Discovery Innovative Treatment Approach for Cancer-Related Cachexia
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Analyzing Gene Expression and Codon Usage Bias in Diverse Genomes Using a Variety of Models
Current Bioinformatics Spirooxindoles as Potential Pharmacophores
Mini-Reviews in Medicinal Chemistry Molecular Mechanisms in Rheumatic Diseases: Rationale for Novel Drug Development – Introduction
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry A Novel Functional Approach Toward Identifying Definitive Drug Targets
Current Medicinal Chemistry Metathesis Reactions. General Considerations
Current Topics in Medicinal Chemistry Current Approaches and Future Prospects of Nanomedicine in Tuberculosis Therapy
Recent Patents on Anti-Infective Drug Discovery A Case of Pulmonary Tuberculosis Mimicking as Diffuse Alveolar Hemorrhage: A Case Report
New Emirates Medical Journal Editorial [Hot Topic: New Drug Targets for the Treatment of Asthma (Guest Editor: D. Knight)]
Current Drug Targets Patent Selections:
Recent Patents on Anti-Infective Drug Discovery